» Articles » PMID: 33050321

Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial

Abstract

Supervised exercise dietary programs are recommended to relieve cancer-related fatigue and weight increase induced by adjuvant treatment of early breast cancer (EBC). As this recommendation lacks a high level of evidence, we designed a multicenter randomized trial to evaluate the impact of an Adapted Physical Activity Diet (APAD) education program on fatigue. We randomized 360 women with EBC who were receiving adjuvant chemotherapy and radiotherapy to APAD or usual care at eight French cancer institutions. Data were collected at baseline, end of chemotherapy, end of radiotherapy, and 6 months post-treatment. The primary endpoint was the general cancer-related fatigue score using the MFI-20 questionnaire. Fatigue correlated with the level of precariousness, but we found no significant difference between the two groups in terms of general fatigue ( = 0.274). The APAD arm has a smaller proportion of patients with confirmed depression at the end of follow-up ( = 0.052). A transient modification in physical activity levels and dietary intake was reported in the experimental arm. However, a mixed hospital- and home-based APAD education program is not enough to improve fatigue caused by adjuvant treatment of EBC. Cancer care centers should consider integrating more proactive diet-exercise supportive care in this population, focusing on precarious patients.

Citing Articles

Nutritional Counseling During Chemotherapy Treatment: A Systematic Review of Feasibility, Safety, and Efficacy.

James S, Oppermann A, Schotz K, Minotti M, Rao G, Kleckner I Curr Oncol. 2025; 32(1).

PMID: 39851919 PMC: 11764068. DOI: 10.3390/curroncol32010003.


The effectiveness of exercise and/or nutritional interventions to improve the quality of life of women with breast cancer receiving radiation therapy: a scoping review.

Feighan L, MacDonald-Wicks L, Callister R, Surjan Y Support Care Cancer. 2024; 32(11):745.

PMID: 39441426 PMC: 11499338. DOI: 10.1007/s00520-024-08933-1.


The combined effect of physical exercise, pranayama, and diet on fatigue in adult cancer patients undergoing chemotherapy: a randomized controlled trial.

Mehta S, Joshi A, Ramteke M, Tandiya P Support Care Cancer. 2024; 32(9):618.

PMID: 39207544 DOI: 10.1007/s00520-024-08821-8.


Impact of Diet Modifications on Body Weight, Body Composition, Treatment Outcomes, and Quality of Life During Primary Treatment for Breast Cancer: A Systematic Review.

Chakos K, Pezley L, Bryner A, Czyzewski O, Corral J, Marquina V Nutr Rev. 2024; 83(3):479-502.

PMID: 39190892 PMC: 11819483. DOI: 10.1093/nutrit/nuae109.


Impact of rehabilitation unit-based physical activity therapy versus symptomatic supportive treatment on older patients with advanced cancer: a non-randomized controlled study.

Lu X, Wei S, Liang B, Huang C, Meng W, Zhang X Support Care Cancer. 2024; 32(8):514.

PMID: 39007999 PMC: 11249417. DOI: 10.1007/s00520-024-08701-1.


References
1.
Roza A, Shizgal H . The Harris Benedict equation reevaluated: resting energy requirements and the body cell mass. Am J Clin Nutr. 1984; 40(1):168-82. DOI: 10.1093/ajcn/40.1.168. View

2.
Carayol M, Romieu G, Bleuse J, Senesse P, Gourgou-Bourgade S, Sari C . Adapted physical activity and diet (APAD) during adjuvant breast cancer therapy: design and implementation of a prospective randomized controlled trial. Contemp Clin Trials. 2013; 36(2):531-43. DOI: 10.1016/j.cct.2013.09.016. View

3.
An K, Morielli A, Kang D, Friedenreich C, McKenzie D, Gelmon K . Effects of exercise dose and type during breast cancer chemotherapy on longer-term patient-reported outcomes and health-related fitness: A randomized controlled trial. Int J Cancer. 2019; 146(1):150-160. DOI: 10.1002/ijc.32493. View

4.
Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View

5.
Eisinger F, Viguier J, Touboul C, Coscas Y, Pivot X, Blay J . Social stratification, risk factor prevalence and cancer screening attendance. Eur J Cancer Prev. 2015; 24 Suppl:S77-81. DOI: 10.1097/CEJ.0000000000000144. View